Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.

Hainstock MR, Fleming G, Kim D, Aboulhosn J, Levi D, Krasuski R, Sommer R, Torres AJ, Gray R, Kereiakes D, Leventhal A, Gillespie M, Szeto W, Zajarias A, Shahanavaz S, Steinberg ZL, Jones TK, Mahadevan VS, Moore P, Elmariah S, Shirali G, Li W, Babaliaros V, Lim DS, COMPASSION 3 Trial Executive Committee and Study Investigators

Open source

DOI
10.1161/circinterventions.125.016361
Published
2026 May
Container
Circulation. Cardiovascular interventions
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/circinterventions.125.016361,
  title = {Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.},
  author = {Hainstock MR and Fleming G and Kim D and Aboulhosn J and Levi D and Krasuski R and Sommer R and Torres AJ and Gray R and Kereiakes D and Leventhal A and Gillespie M and Szeto W and Zajarias A and Shahanavaz S and Steinberg ZL and Jones TK and Mahadevan VS and Moore P and Elmariah S and Shirali G and Li W and Babaliaros V and Lim DS and COMPASSION 3 Trial Executive Committee and Study Investigators},
  year = {2026},
  journal = {Circulation. Cardiovascular interventions},
  doi = {10.1161/circinterventions.125.016361},
  url = {https://doi.org/10.1161/circinterventions.125.016361}
}

RIS

TY  - JOUR
TI  - Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.
AU  - Hainstock MR
AU  - Fleming G
AU  - Kim D
AU  - Aboulhosn J
AU  - Levi D
AU  - Krasuski R
AU  - Sommer R
AU  - Torres AJ
AU  - Gray R
AU  - Kereiakes D
AU  - Leventhal A
AU  - Gillespie M
AU  - Szeto W
AU  - Zajarias A
AU  - Shahanavaz S
AU  - Steinberg ZL
AU  - Jones TK
AU  - Mahadevan VS
AU  - Moore P
AU  - Elmariah S
AU  - Shirali G
AU  - Li W
AU  - Babaliaros V
AU  - Lim DS
AU  - COMPASSION 3 Trial Executive Committee and Study Investigators
PY  - 2026
JO  - Circulation. Cardiovascular interventions
DO  - 10.1161/circinterventions.125.016361
UR  - https://doi.org/10.1161/circinterventions.125.016361
ER  - 

APA

MR, H., G, F., D, K., J, A., D, L., R, K., R, S., AJ, T., R, G., D, K., A, L., M, G., W, S., A, Z., S, S., ZL, S., TK, J., VS, M., P, M., S, E., G, S., W, L., V, B., DS, L., & Investigators, C. 3. T. E. C. A. S. (2026). Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.. Circulation. Cardiovascular interventions. https://doi.org/10.1161/circinterventions.125.016361

Source records